MCOLN1 and glioblastoma: In human glioblastoma patients, on the other hand, TRPML1 expression is decreased in comparison to that of healthy astrocytes and TRPML1 knockdown is able to attenuate autophagic cell death upon potent ROS inducer challenge [31].